Methylene blue and Cefazolin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methylene blue (methylene blue) and Cefazolin (cefazolin sodium). Common drug interactions include circulatory collapse among females and serotonin syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Methylene blue and Cefazolin. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.
What is Methylene blue?
Methylene blue has active ingredients of methylene blue. eHealthMe is studying from 1,061 Methylene blue users. Check the latest studies of Methylene blue.
What is Cefazolin?
Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.
33 people who take Methylene blue and Cefazolin together, and have interactions are studied.

What are the common drug interactions of Methylene Blue and Cefazolin, by gender? *:
female:
- Circulatory collapse
- Pulseless electrical activity
- Anaphylactic reaction (serious allergic reaction)
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
- Drug effect decreased
- Hypotension (abnormally low blood pressure)
male:
- Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Trismus (reduced opening of the jaws)
- Burkholderia test positive
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Agitation (state of anxiety or nervous excitement)
- Confusional state
- Hypertension (high blood pressure)
- Restlessness (not able to rest)
- Sepsis (a severe blood infection that can lead to organ failure and death)
What are the common drug interactions of Methylene Blue and Cefazolin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Blood creatinine increased
- Pseudomonal sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas)
- Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
- White blood cell count increased
- Hyperreflexia (overactive or over responsive reflexes)
- Muscle rigidity (muscle stiffness)
- Nystagmus (a condition of involuntary eye movement)
30-39:
- Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
- Anaphylactic reaction (serious allergic reaction)
40-49:
- Drug effect decreased
- Drug ineffective
- Hypotension (abnormally low blood pressure)
- Circulatory collapse
- Pulseless electrical activity
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
50-59:
- Burkholderia test positive
- Respiratory disorder (respiratory disease)
- Sputum culture positive
- Syncope (loss of consciousness with an inability to maintain postural tone)
60+:
- Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
- Hyperkalaemia (damage to or disease of the kidney)
- Immunosuppressant drug level increased
What are the existing conditions these people have? *
- Depression: 19 people, 57.58%
- Pain: 18 people, 54.55%
- General Anaesthesia: 7 people, 21.21%
- Neuromuscular Blockade Reversal: 6 people, 18.18%
- Anaesthesia: 5 people, 15.15%
- Sedation: 3 people, 9.09%
- Hypotonia (low muscle tone): 3 people, 9.09%
- Appendicitis (inflammation of the appendix): 3 people, 9.09%
- Vasoplegia Syndrome (low systemic vascular resistance): 2 people, 6.06%
- Neuromuscular Blockade: 2 people, 6.06%
* Approximation only. Some reports may have incomplete information.
Do you take Methylene blue and Cefazolin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methylene blue (1,061 reports)
- Cefazolin (15,157 reports)
Browse all drug interactions of Methylene blue and Cefazolin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methylene blue:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cefazolin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methylene blue and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefazolin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methylene blue and cefazolin sodium (the active ingredients of Methylene blue and Cefazolin, respectively), and Methylene blue and Cefazolin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Nexium cause Renal Neoplasm? - 2 seconds ago
- Drug interactions of Metformin and Kalbitor - 7 seconds ago
- Drug interactions of Clarithromycin and Fortical - 15 seconds ago
- Could Zantac cause Blood Amylase Increased? - 19 seconds ago
- Fibromyalgia and Drug Eruption - 26 seconds ago
- Drug interactions of Danazol and Frovatriptan Succinate - 35 seconds ago
- Could Flagyl cause Monocyte Percentage Increased? - 38 seconds ago
- Could Forteo cause Myasthenia Gravis? - 42 seconds ago
- Could Azacitidine cause Epstein-Barr Virus Infection? - 48 seconds ago
- Drug interactions of Sinequan and Acidophilus - 51 seconds ago